D-1,2,3,4-tetrahydronorharmane-3-carboxylic acid

D-1,2,3,4-Tetrahydronorharmane-3-carboxylic acid is a D-configured, cyclic amino-acid-like heterocycle bearing a carboxylic acid at the 3-position and a saturated tetrahydro-fused norharmane framework that functions as a rigid, chiral scaffold. The molecule presents a stereogenic center associated with the D-configuration, along with a benzylic-like ring system that can influence conformational preferences during coupling and downstream derivatization. The free carboxyl group enables standard peptide coupling chemistries after activation, while the ring nitrogens and aromatic-like electron distribution can affect salt formation, solubility, and reactivity under acidic or basic conditions. As a chiral heterocycle-containing amino acid intermediate, it can be incorporated into peptide-like constructs or transformed into protected derivatives to support stereochemically controlled synthesis and structure-guided molecular design.

1. Peptide Synthesis

D-1,2,3,4-Tetrahydronorharmane-3-carboxylic acid is applied in peptide building workflows where amino-acid-like carboxyl functionality enables amide bond formation to install the tetrahydronorharmane stereocenter into peptide backbones. The rigid, fused cyclic structure can serve as a conformationally biasing residue, and the D-configuration supports stereochemically defined coupling products for subsequent deprotection and chain elongation strategies. Carboxyl activation followed by nucleophilic acyl substitution with protected amines can yield peptide segments that retain the heterocycle's structural integrity. Downstream, the resulting peptide or peptidomimetic analogs can be used as research-grade substrates for studying sequence-dependent conformational effects and heterocycle incorporation in amino acid chemistry.

2. Chiral Building Blocks

D-1,2,3,4-Tetrahydronorharmane-3-carboxylic acid is suitable for chiral synthesis programs that require a stereodefined heterocyclic amino-acid intermediate rather than a simple open-chain amino acid. The D stereocenter at the carboxyl-bearing carbon enables stereospecific derivatization, while the tetrahydro-fused norharmane framework provides a rigid 3D shape that can be preserved through protection, activation, and coupling steps. Carboxylic acid functionalization to protected forms, such as esterification or carboxyl protection, can support orthogonal strategies with other functional groups during multi-step synthesis. The compound can therefore be employed to generate stereochemically defined libraries of amino acid derivatives and peptide-like scaffolds for chiral recognition and structure-guided design.

3. Side-Chain Functionalization

D-1,2,3,4-Tetrahydronorharmane-3-carboxylic acid is used for side-chain and scaffold functionalization routes where the carboxylic acid serves as a handle for conversion into activated intermediates and conjugatable derivatives. The heterocyclic ring system can be retained while the carboxyl group is transformed into amide, ester, or activated ester derivatives to introduce additional functional motifs for molecular recognition studies. Protecting-group selection for the acid and any ring-associated basic sites can be leveraged to control chemoselectivity during sequential modifications, including late-stage coupling to amines or incorporation into peptidomimetic structures. The resulting functionalized heterocycle-containing amino acid derivatives can support downstream molecular assembly, including derivatization for analytical standards, fragment elaboration, or scaffold diversification in fine chemical synthesis.

4. Chemical Biology Probes

D-1,2,3,4-Tetrahydronorharmane-3-carboxylic acid is applicable to chemical biology research where heterocycle-containing amino acid analogs are incorporated into peptide-like probes to interrogate binding interactions and conformational preferences. The carboxyl group enables attachment to peptide carriers or probe scaffolds, while the D-configured tetrahydronorharmane ring can modulate local geometry and electronic character relative to standard residues. Protected amino-acid derivative strategies can support incorporation at defined positions during solid-phase or solution-phase peptide construction, enabling site-specific probe generation. Downstream probe constructs can be used as research reagents for studying structure-function relationships, including how rigid chiral heterocycles influence molecular recognition in biochemical assays.

5. Pharmaceutical Intermediate Preparation

D-1,2,3,4-Tetrahydronorharmane-3-carboxylic acid is relevant to pharmaceutical intermediate preparation where a chiral, heterocyclic amino-acid-like motif is required for synthesis of peptide-inspired or heterocycle-rich drug-like candidates. The free carboxylic acid provides a reliable entry point for process-compatible activation and conversion into protected forms that can be carried through multi-step synthetic sequences with controlled stereochemical outcomes. The rigid tetrahydronorharmane framework can be maintained during downstream coupling or derivatization, supporting manufacture of stereodefined building blocks for medicinal chemistry and applied process chemistry. The compound can thus serve as a chiral intermediate for producing protected amino acid derivatives and coupling-ready intermediates used in fine chemical synthesis and specialty chemical production pipelines.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes